Proton beam therapy combined with intra-arterial infusion chemotherapy for stage Ⅳ adenoid cystic carcinoma of the base of the tongue

Abstract

Adenoid cystic carcinoma （ACC） is a very rare epithelial tumor of the salivary glands. Surgical resection is considered to be a standard therapy. However, the optimal treatment strategy for managing advanced cases has not yet been established. This study evaluated the efficacy and toxicity of proton beam therapy （PBT） combined with selective intra-arterial infusion chemotherapy （IAIC） using weekly cisplatin for locally advanced ACC of the base of the tongue. Between March 2009 and February 2018, 15 patients were treated. The median follow-up duration was 56 （range: 15-116） months. The 5-year local control and overall survival rates were 89％ and 76％, respectively. With regard to late toxicities, grade 2 osteoradionecrosis was found in one patient and grade 5 pharyngeal necrosis in one patient. Considering most cases were signi?cantly advanced and inoperable, this therapy was effective in controlling the primary tumor, preserving function and maintaining quality of life. Although improvements are needed to reduce adverse events, PBT in combination with IAIC can be a treatment option for locally advanced ACC of the base of the tongue.